Remipharma MB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
9,716 |
- |
-812 |
-812 |
- |
100.00 |
-8.36 |
-712 |
8,635 |
697 |
7,226 |
2023 |
---|
57,085 |
- |
27,656 |
26,261 |
- |
99.81 |
46.00 |
25,550 |
11,717 |
444 |
36,823 |
2024 |
---|
57,620 |
- |
37,528 |
35,991 |
- |
93.58 |
62.46 |
61,539 |
5,058 |
1,531 |
65,066 |
Register and
explore Okredo data2024 |
---|
57,620 |
- |
37,528 |
35,991 |
- |
93.58 |
62.46 |
61,539 |
5,058 |
1,531 |
65,066 |
Register and
explore Okredo data2024
Turnover (€)
57,620 €1 % *
Sales per employee (€)
-Profit before tax (€)
37,528 €36 % *
Net Profit (€)
35,991 €37 % *
Profit per employee (€)
-Total profitability (%)
93.58 %-6.24 % *
Net profitability (%)
62.46 %35.78 % *
Equity (€)
61,539 €141 % *
Amounts Payable And Liabilities (€)
5,058 €-57 % *
Non-current Assets (€)
1,531 €245 % *
CurrentAssets (€)
65,066 €77 % *